Literature DB >> 28743060

Glucose fluctuation and the resultant endothelial injury are correlated with pancreatic β cell dysfunction in patients with coronary artery disease.

Makoto Murata1, Hitoshi Adachi2, Shigeru Oshima3, Masahiko Kurabayashi4.   

Abstract

AIMS: We evaluated whether glucose fluctuation (GF) causes vascular endothelial injury and affects glucometabolic factors during lengthy oral glucose tolerance test (OGTT).
METHODS: We enrolled consecutive 116 patients with coronary artery disease (CAD) who were performed coronary angiography and 4-h OGTT. Blood samples were collected before and 4h after glucose load to measure endothelial injury factor [von Willebrand factor (vWF) and vWF/a disintegrin-like and metalloproteinase with thrombospondin type-1 motifs 13 (ADAMTS-13) ratio]. GF was defined as maximum - minimum blood glucose levels during 4-h OGTT. We estimated the relationship between GF and glucometabolic factors.
RESULTS: vWV and vWF/ADAMTS-13 ratio were significantly correlated with GF during 4-h OGTT. GF was significantly correlated with homeostasis model to assess insulin resistance (HOMA-IR) (R=0.262), Matsuda index (R=-0.405), insulinogenic index (R=-0.336), HbA1c (R=0.281) and disposition index (R=-0.672). When dividing patients into impaired and preserved category groups according to the average value of GF (122mg/dL), adjusted to age, sex, HOMA-β, insulinogenic index, HOMA-IR, Matsuda index and HbA1c, disposition index was an independent risk factor for impaired GF [odds ratio (95% confidence interval): 2.87 (1.70-4.83), P<0.001].
CONCLUSION: Pancreatic β cell dysfunction is associated with GF and causes endothelial injury in CAD patients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Beta cell function; Coronary artery disease; Endothelial cell function; Oral glucose tolerance test; Pre-diabetes

Mesh:

Substances:

Year:  2017        PMID: 28743060     DOI: 10.1016/j.diabres.2017.07.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  An Intelligent Nanoscale Insulin Delivery System.

Authors:  Wei Wang; Ling Liao; Xiaobing Zhang; Fan Lei; Yaou Zhang; Gan Liu; Weidong Xie
Journal:  Molecules       Date:  2018-11-11       Impact factor: 4.411

2.  Association between glucose fluctuation during 2-hour oral glucose tolerance test, inflammation and oxidative stress markers, and β-cell function in a Chinese population with normal glucose tolerance.

Authors:  Chifa Ma; Yiwen Liu; Shuli He; Jingbo Zeng; Pingping Li; Chunxiao Ma; Fan Ping; Huabing Zhang; Lingling Xu; Wei Li; Yuxiu Li
Journal:  Ann Transl Med       Date:  2021-02

3.  Sex-Specific Associations Between Low Muscle Mass and Glucose Fluctuations in Patients With Type 2 Diabetes Mellitus.

Authors:  Xiulin Shi; Wenjuan Liu; Lulu Zhang; Fangsen Xiao; Peiying Huang; Bing Yan; Yiping Zhang; Weijuan Su; Qiuhui Jiang; Mingzhu Lin; Wei Liu; Xuejun Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-13       Impact factor: 6.055

Review 4.  Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications.

Authors:  Zhen-Ye Zhang; Ling-Feng Miao; Ling-Ling Qian; Ning Wang; Miao-Miao Qi; Yu-Min Zhang; Shi-Peng Dang; Ying Wu; Ru-Xing Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-09-18       Impact factor: 5.555

5.  iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post-hoc analysis of the LixiLan JP-L trial.

Authors:  Daisuke Yabe; Katsumi Iizuka; Mike Baxter; Daisuke Watanabe; Hideaki Kaneto
Journal:  J Diabetes Investig       Date:  2021-06-19       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.